Table 3.
SAE description | Events, n |
---|---|
New ascites | 1 |
Renal impairment | 1 |
Variceal bleeding (death) | 3 |
Variceal bleeding (death) | 1 |
Pneumonia (death) | 1 |
Death (decompensated cirrhosis) | 4 |
Bronchogenic carcinoma and pleural effusion (death) | 1 |
Total deaths in trial treatment period | 8 (10%) |
SAE, serious adverse event.